Cinnatropin Somatropin 5mg Injection Pack of 6 In Pakistan
Cinnatropin Somatropin 5mg Injection Pack of 6 In Pakistan
Cinnatropin 5mg/1.5mL contains somatropin, a recombinant form of human growth hormone (GH). It is a prescription medicine used for specific growth hormone-related conditions when treatment is medically indicated. Cinnatropin is supplied as a 5mg/1.5mL injection and this pack contains 6 units. Treatment should be started and monitored by a qualified healthcare professional.
Key Benefits
- Provides recombinant human growth hormone for medically indicated treatment.
- Supports growth and development in eligible patients with growth hormone deficiency.
- May be used for other approved somatropin indications depending on age, diagnosis, and local prescribing guidelines.
- 5mg/1.5mL presentation for prescribed treatment.
- Pack of 6 convenient injection units.
How to Use
Use Cinnatropin exactly as prescribed by an endocrinologist or other qualified healthcare professional. Somatropin is administered by subcutaneous injection, and the appropriate dose depends on the patient's diagnosis, age, body weight or body surface area, treatment response, and other clinical factors. Do not self-adjust the dose or use somatropin for bodybuilding, height enhancement after growth plates have closed, or weight loss unless specifically medically indicated.
Follow the manufacturer's instructions for preparation, injection technique, storage, and handling. Do not use a damaged, expired, improperly stored, or visibly altered product.
Safety Information
Somatropin is a prescription medicine and requires appropriate medical assessment and monitoring. It should generally not be used in patients with active malignancy, certain acute critical illnesses, known hypersensitivity to somatropin or its ingredients, or active severe diabetic retinopathy. Somatropin should not be used for growth promotion in children with closed growth plates.
Treatment may affect blood glucose and insulin sensitivity and can cause fluid retention. Other important risks include intracranial hypertension, hypersensitivity reactions, and possible effects on existing or previously treated tumors. Patients with diabetes, endocrine disorders, a history of tumors, or other significant medical conditions should inform their healthcare professional before treatment.
Possible adverse effects may include injection-site reactions, headache, joint or muscle discomfort, swelling, and other effects related to fluid retention or changes in glucose metabolism. Seek medical attention for severe allergic reactions, significant headaches or visual changes, breathing problems, or other serious symptoms.
Keep Cinnatropin refrigerated and follow the manufacturer's specific storage requirements. Verify the manufacturer, batch number, expiry date, packaging, and authenticity before use. Use only under qualified medical supervision.